Tamoxifen Initiation After Ductal Carcinoma In Situ

BACKGROUND. Endocrine therapy initiation after ductal carcinoma in situ (DCIS) is highly variable and largely unexplained. National guidelines recommend considering tamoxifen for women with estrogen receptor-positive (ER+) DCIS or who undergo excision alone. We evaluated endocrine therapy use after...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Nichols, Hazel B., Bowles, Erin J.A., Islam, Jessica, Madziwa, Lawrence, Stürmer, Til, Tran, Diem-Thy, Buist, Diana S.M.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746086/
https://ncbi.nlm.nih.gov/pubmed/26768485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0310
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados